Laura Segatori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Segatori has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
Carlos D. Llanos
Rice University
6 shared publicationsBhagyashree Bachhav
Department of Chemical and Biomolecular Engineering, Rice University, Houston, USA
5 shared publicationsWenting Zhao
Department of Chemical and Biomolecular Engineering, Rice University, Houston, Texas 77005, United States
5 shared publicationsYimeng Zeng
Department of Chemical and Biomolecular Engineering, Rice University, Houston, Texas 77005, United States
5 shared publicationsFan Wang
Rice University
4 shared publications- Zachary Thomas Ball
Rice University
4 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
Dynamic Cell Factories for Feedback Regulated Expression of Therapeutic Proteins
The biomanufacturing of complex therapeutic proteins is often limited by endoplasmic reticulum (ER) stress and chronic activation of the unfolded protein response (UPR), which leads to apoptosis and reduced productivity. Traditional engineering strategiesrelying on constitutive modulationfrequently fail due to the emergence of secondary bottlenecks, disruption of endogenous homeostasis, and an inability to account for clonal variations or temporal fluctuations in cellular folding capacity over the course of a bioprocess. Here, we report the development of feedback-responsive cell factories that sense proteotoxic stress and dynamically modulate therapeutic transgene expression in real time, utilizing a closed-loop “sense-and-respond” architecture. We demonstrate that this approach mitigates ER stress and preserves cell viability without compromising overall protein production. This framework significantly enhanced the titers of two challenging therapeutic candidates: the bispecific antibody blinatumomab and tissue plasminogen activator (tPA). Our findings establish a proof-of-concept framework for the dynamic management of cellular stress, offering a valuable strategy that could be adapted to optimize the bioproduction of complex biologics.
- 13 November 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
Open AccessDynamic Cell Factories for Feedback Regulated Expression of Therapeutic Proteins
The biomanufacturing of complex therapeutic proteins is often limited by endoplasmic reticulum (ER) stress and chronic activation of the unfolded protein response (UPR), which leads to apoptosis and reduced productivity. Traditional engineering strategiesrelying on constitutive modulationfrequently fail due to the emergence of secondary bottlenecks, disruption of endogenous homeostasis, and an inability to account for clonal variations or temporal fluctuations in cellular folding capacity over the course of a bioprocess. Here, we report the development of feedback-responsive cell factories that sense proteotoxic stress and dynamically modulate therapeutic transgene expression in real time, utilizing a closed-loop “sense-and-respond” architecture. We demonstrate that this approach mitigates ER stress and preserves cell viability without compromising overall protein production. This framework significantly enhanced the titers of two challenging therapeutic candidates: the bispecific antibody blinatumomab and tissue plasminogen activator (tPA). Our findings establish a proof-of-concept framework for the dynamic management of cellular stress, offering a valuable strategy that could be adapted to optimize the bioproduction of complex biologics.
- Open Access
- 27 March 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (4) , 1300-1311
Establishing an RNA Sensor with High Sensitivity and Dynamic Range Utilizing a Signal Amplifier Platform
Precise control of gene expression in a cell-state-specific manner is essential for effective therapeutic interventions in complex and dynamic disease microenvironments. Traditional targeting strategies that rely on surface markers or cell type-specific promoters often assume static cellular identities, limiting effectiveness in context such as cancer and inflammation, where cell states are highly heterogeneous and dynamic. RNA sensors, such as RADAR (RNA sensing using Adenosine Deaminases Acting on RNA), provide a modular, programmable, and nonintegrating platform for classifying cell states. However, it is also characterized by low sensitivity and dynamic range, which limits its applications in detecting low-abundance transcripts. In this work, we integrate RADAR sensors with a signal amplification circuit to enhance sensitivity and dynamic range. We demonstrate that this combined RADAR-amplifier platform enables real-time monitoring of subtle changes in the abundance of endogenous transcripts under physiological conditions. Our results demonstrate the utility of this platform for fundamental biological studies and the development of precision therapeutic strategies.
- 27 March 2026
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (4) , 1300-1311
Open AccessEstablishing an RNA Sensor with High Sensitivity and Dynamic Range Utilizing a Signal Amplifier Platform
Precise control of gene expression in a cell-state-specific manner is essential for effective therapeutic interventions in complex and dynamic disease microenvironments. Traditional targeting strategies that rely on surface markers or cell type-specific promoters often assume static cellular identities, limiting effectiveness in context such as cancer and inflammation, where cell states are highly heterogeneous and dynamic. RNA sensors, such as RADAR (RNA sensing using Adenosine Deaminases Acting on RNA), provide a modular, programmable, and nonintegrating platform for classifying cell states. However, it is also characterized by low sensitivity and dynamic range, which limits its applications in detecting low-abundance transcripts. In this work, we integrate RADAR sensors with a signal amplification circuit to enhance sensitivity and dynamic range. We demonstrate that this combined RADAR-amplifier platform enables real-time monitoring of subtle changes in the abundance of endogenous transcripts under physiological conditions. Our results demonstrate the utility of this platform for fundamental biological studies and the development of precision therapeutic strategies.
- Open Access
Establishing an RNA sensor with high sensitivity and dynamic range utilizing a signal amplifier platform
Precise control of gene expression in a cell-state-specific manner is essential for effective therapeutic interventions in complex and dynamic disease microenvironments. Traditional targeting strategies that rely on surface markers or cell type-specific promoters often assume static cellular identities, limiting effectiveness in contexts such as cancer and inflammation, where cell states are highly heterogeneous and dynamic. RNA sensors, such as RADAR (RNA sensing using Adenosine Deaminases Acting on RNA), provide a modular, programmable, and non-integrating platform for classifying cell states. However, it is also characterized by low sensitivity and dynamic range, which limits its applications in detecting low-abundance transcripts. In this work, we integrate RADAR sensors with a signal amplification circuit to enhance sensitivity and dynamic range. We demonstrate that this combined RADAR-amplifier platform enables real-time monitoring of subtle changes in the abundance of endogenous transcripts under physiological conditions. Our results demonstrate the utility of this platform for fundamental biological studies and the development of precision therapeutic strategies. Abstract Figure:
Open AccessEstablishing an RNA sensor with high sensitivity and dynamic range utilizing a signal amplifier platform
Precise control of gene expression in a cell-state-specific manner is essential for effective therapeutic interventions in complex and dynamic disease microenvironments. Traditional targeting strategies that rely on surface markers or cell type-specific promoters often assume static cellular identities, limiting effectiveness in contexts such as cancer and inflammation, where cell states are highly heterogeneous and dynamic. RNA sensors, such as RADAR (RNA sensing using Adenosine Deaminases Acting on RNA), provide a modular, programmable, and non-integrating platform for classifying cell states. However, it is also characterized by low sensitivity and dynamic range, which limits its applications in detecting low-abundance transcripts. In this work, we integrate RADAR sensors with a signal amplification circuit to enhance sensitivity and dynamic range. We demonstrate that this combined RADAR-amplifier platform enables real-time monitoring of subtle changes in the abundance of endogenous transcripts under physiological conditions. Our results demonstrate the utility of this platform for fundamental biological studies and the development of precision therapeutic strategies. Abstract Figure:
- 21 May 2025
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 36 (6) , 1157-1168
Novel Approaches to Label the Surface of S. aureus with DBCO for Click Chemistry-Mediated Deposition of Sensitive Cargo
The strain-promoted alkyne-azide cycloaddition (SPAAC) reaction can be used to modify the surface of bacteria for a variety of applications including drug delivery, biosensing, and imaging. This is usually accomplished by first installing a small azide group within the peptidoglycan and then delivering exogenous cargo (e.g., a protein or nanoparticle) modified with a cyclooctyne group, such as dibenzocyclooctyne (DBCO), for in situ conjugation. However, DBCO is comparatively bulky and hydrophobic, increasing the propensity of some payloads to aggregate. In this study, we sought to invert this paradigm by exploring two novel strategies for incorporating DBCO into the peptidoglycan of Staphylococcus aureus and compared them to an established approach using DBCO-vancomycin. We demonstrate that DBCO-modified small molecules belonging to all three classes─a sortase peptide substrate (LPETG), two d-alanine derivatives, and vancomycin─can selectively label the S. aureus surface to varying degrees. In contrast to DBCO-vancomycin, the DBCO-d-alanine variants do not adversely affect the growth of S. aureus or lead to off-target labeling or toxicity in HEK293T or RAW 264.7 cells. Finally, we show that, unlike IgG3-Fc labeled with DBCO groups, IgG3-Fc labeled with azide groups is stable (i.e., remains water-soluble) under normal storage conditions, retains its ability to bind the immune receptor CD64, and can be successfully attached to the surface of DBCO-modified S. aureus. We believe that the labeling strategies explored herein will expand the paradigm of specific, nontoxic SPAAC-mediated labeling of the surface of S. aureus and other Gram-positive bacteria, opening the door for new applications using azide-modified cargo.
- 21 May 2025
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 36 (6) , 1157-1168
Novel Approaches to Label the Surface of S. aureus with DBCO for Click Chemistry-Mediated Deposition of Sensitive Cargo
The strain-promoted alkyne-azide cycloaddition (SPAAC) reaction can be used to modify the surface of bacteria for a variety of applications including drug delivery, biosensing, and imaging. This is usually accomplished by first installing a small azide group within the peptidoglycan and then delivering exogenous cargo (e.g., a protein or nanoparticle) modified with a cyclooctyne group, such as dibenzocyclooctyne (DBCO), for in situ conjugation. However, DBCO is comparatively bulky and hydrophobic, increasing the propensity of some payloads to aggregate. In this study, we sought to invert this paradigm by exploring two novel strategies for incorporating DBCO into the peptidoglycan of Staphylococcus aureus and compared them to an established approach using DBCO-vancomycin. We demonstrate that DBCO-modified small molecules belonging to all three classes─a sortase peptide substrate (LPETG), two d-alanine derivatives, and vancomycin─can selectively label the S. aureus surface to varying degrees. In contrast to DBCO-vancomycin, the DBCO-d-alanine variants do not adversely affect the growth of S. aureus or lead to off-target labeling or toxicity in HEK293T or RAW 264.7 cells. Finally, we show that, unlike IgG3-Fc labeled with DBCO groups, IgG3-Fc labeled with azide groups is stable (i.e., remains water-soluble) under normal storage conditions, retains its ability to bind the immune receptor CD64, and can be successfully attached to the surface of DBCO-modified S. aureus. We believe that the labeling strategies explored herein will expand the paradigm of specific, nontoxic SPAAC-mediated labeling of the surface of S. aureus and other Gram-positive bacteria, opening the door for new applications using azide-modified cargo.
- Open Access
- 2 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Feedback-responsive cell factories for dynamic modulation of the unfolded protein response
Engineering cell factories that support the production of large quantities of protein therapeutics remains a significant biomanufacturing challenge. The overexpression of secretory proteins causes proteotoxic stress, affecting cell viability and protein productivity. Proteotoxic stress leads to the activation of the Unfolded Protein Response (UPR), a series of signal transduction pathways regulating protein quality control mechanisms aimed at restoring homeostasis. Sustained UPR activation culminates with the induction of apoptosis. Current strategies for enhancing the production of therapeutic proteins have focused on the deregulated modulation of key components of the UPR. These strategies have resulted in limited and often protein-specific improvements as they may lead to adaptation and cell toxicity and do not account for natural population heterogeneities. We report here feedback-responsive cell factories that sense proteotoxic stress and, in response, modulate the UPR to enhance stress attenuation and delay cell death, addressing the limitations of current strategies. We demonstrate that our cell engineering approach enables dynamic UPR modulation upon proteotoxic stress. The sense-and-respond systems that mediate dynamic UPR modulation enhance the production of the therapeutic enzyme tissue plasminogen activator and the bispecific antibody blinatumomab. Our feedback-responsive cell factories provide an innovative strategy for dynamically adjusting the innate cellular stress response and enhancing therapeutic protein manufacturing.
- 2 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Open AccessFeedback-responsive cell factories for dynamic modulation of the unfolded protein response
Engineering cell factories that support the production of large quantities of protein therapeutics remains a significant biomanufacturing challenge. The overexpression of secretory proteins causes proteotoxic stress, affecting cell viability and protein productivity. Proteotoxic stress leads to the activation of the Unfolded Protein Response (UPR), a series of signal transduction pathways regulating protein quality control mechanisms aimed at restoring homeostasis. Sustained UPR activation culminates with the induction of apoptosis. Current strategies for enhancing the production of therapeutic proteins have focused on the deregulated modulation of key components of the UPR. These strategies have resulted in limited and often protein-specific improvements as they may lead to adaptation and cell toxicity and do not account for natural population heterogeneities. We report here feedback-responsive cell factories that sense proteotoxic stress and, in response, modulate the UPR to enhance stress attenuation and delay cell death, addressing the limitations of current strategies. We demonstrate that our cell engineering approach enables dynamic UPR modulation upon proteotoxic stress. The sense-and-respond systems that mediate dynamic UPR modulation enhance the production of the therapeutic enzyme tissue plasminogen activator and the bispecific antibody blinatumomab. Our feedback-responsive cell factories provide an innovative strategy for dynamically adjusting the innate cellular stress response and enhancing therapeutic protein manufacturing.
- Open Access
Novel approaches to label the surface of S. aureus with DBCO for click chemistry-mediated deposition of sensitive cargo
The strain-promoted alkyne-azide cycloaddition (SPAAC) reaction can be used to modify the surface of bacteria for a variety of applications, including drug delivery, biosensing, and imaging. This is usually accomplished by first installing a small azide group within the peptidoglycan and then delivering exogenous cargo (e.g., a protein or nanoparticle) modified with a cyclooctyne group, such as dibenzocyclooctyne (DBCO), for in situ conjugation. However, DBCO is comparatively bulky and hydrophobic, increasing the propensity for some payloads to aggregate. In this study, we sought to invert this paradigm by exploring two novel strategies for incorporating DBCO into the peptidoglycan of Staphylococcus aureus and compared them to an established approach using DBCO-vancomycin. We demonstrate that DBCO-modified small molecules belonging to all three classes – a sortase peptide substrate (LPETG), two D-alanine derivatives, and vancomycin – can selectively label the S. aureus surface to varying degrees. In contrast to DBCO-vancomycin, the DBCO-D-alanine variants do not adversely affect the growth of S. aureus or lead to off-target labeling or toxicity in HEK293T cells, even at high concentrations. Finally, we show that, unlike IgG3-Fc labeled with DBCO groups, IgG3-Fc labeled with azide groups is stable (i.e., remains water-soluble) under normal storage conditions, retains its ability to bind the immune receptor CD64, and can be successfully attached to the surface of DBCO-modified S. aureus . We believe the labeling strategies explored herein will expand the paradigm of specific, nontoxic SPAAC-mediated labeling of the surface of S. aureus and other gram-positive bacteria, opening the door for new applications using azido-modified cargo. GRAPHICAL
Open AccessNovel approaches to label the surface of S. aureus with DBCO for click chemistry-mediated deposition of sensitive cargo
The strain-promoted alkyne-azide cycloaddition (SPAAC) reaction can be used to modify the surface of bacteria for a variety of applications, including drug delivery, biosensing, and imaging. This is usually accomplished by first installing a small azide group within the peptidoglycan and then delivering exogenous cargo (e.g., a protein or nanoparticle) modified with a cyclooctyne group, such as dibenzocyclooctyne (DBCO), for in situ conjugation. However, DBCO is comparatively bulky and hydrophobic, increasing the propensity for some payloads to aggregate. In this study, we sought to invert this paradigm by exploring two novel strategies for incorporating DBCO into the peptidoglycan of Staphylococcus aureus and compared them to an established approach using DBCO-vancomycin. We demonstrate that DBCO-modified small molecules belonging to all three classes – a sortase peptide substrate (LPETG), two D-alanine derivatives, and vancomycin – can selectively label the S. aureus surface to varying degrees. In contrast to DBCO-vancomycin, the DBCO-D-alanine variants do not adversely affect the growth of S. aureus or lead to off-target labeling or toxicity in HEK293T cells, even at high concentrations. Finally, we show that, unlike IgG3-Fc labeled with DBCO groups, IgG3-Fc labeled with azide groups is stable (i.e., remains water-soluble) under normal storage conditions, retains its ability to bind the immune receptor CD64, and can be successfully attached to the surface of DBCO-modified S. aureus . We believe the labeling strategies explored herein will expand the paradigm of specific, nontoxic SPAAC-mediated labeling of the surface of S. aureus and other gram-positive bacteria, opening the door for new applications using azido-modified cargo. GRAPHICAL
- 13 May 2024
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 35 (6) , 732-736
Templated Synthesis of Copper Nanoclusters with a Hybrid Lysozyme-Polymer Material for Enhanced Fluorescence
Hybrid materials that combine organic polymers and biomacromolecules offer unique opportunities for precisely controlling 3D chemical environments. Although biological or organic templates have been separately used to control the growth of inorganic nanoclusters, hybrid structures represent a relatively unexplored approach to tailoring nanocluster properties. Here, we demonstrate that a molecularly defined lysozyme-polymer resin material acts as a structural scaffold for the synthesis of copper nanoclusters (CuNCs) with well controlled size distributions. The resulting CuNCs have significantly enhanced fluorescence compared with syntheses based on polymeric or biological templates alone. The synergistic approach described here is appealing for the synthesis of biocompatible fluorescent labels with improved photostability.
- 13 May 2024
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 35 (6) , 732-736
Templated Synthesis of Copper Nanoclusters with a Hybrid Lysozyme-Polymer Material for Enhanced Fluorescence
Hybrid materials that combine organic polymers and biomacromolecules offer unique opportunities for precisely controlling 3D chemical environments. Although biological or organic templates have been separately used to control the growth of inorganic nanoclusters, hybrid structures represent a relatively unexplored approach to tailoring nanocluster properties. Here, we demonstrate that a molecularly defined lysozyme-polymer resin material acts as a structural scaffold for the synthesis of copper nanoclusters (CuNCs) with well controlled size distributions. The resulting CuNCs have significantly enhanced fluorescence compared with syntheses based on polymeric or biological templates alone. The synergistic approach described here is appealing for the synthesis of biocompatible fluorescent labels with improved photostability.
- 6 March 2024
- Published by Springer Nature
- Vol. 2774, 99-117
A Computational Modeling Approach for the Design of Genetic Control Systems that Respond to Transcriptional Activity
Recent progress in synthetic biology has enabled the design of complex genetic circuits that interface with innate cellular functions, such as gene transcription, and control user-defined outputs. Implementing these genetic networks in mammalian cells, however, is a cumbersome process that requires several steps of optimization and benefits from the use of predictive modeling. Combining deterministic mathematical models with software-based numerical computing platforms allows researchers to quickly design, evaluate, and optimize multiple circuit topologies to establish experimental constraints that generate the desired control systems. In this chapter, we present a systematic approach based on predictive mathematical modeling to guide the design and construction of gene activity-based sensors. This approach enables user-driven circuit optimization through iterations of sensitivity analyses and parameter scans, providing a universal method to engineer sense and respond cells for diverse applications. Key words Genetic control systems Sense-and-respond Genetic circuits Mammalian synthetic biology Cell therapies
- 6 March 2024
- Published by Springer Nature
- Vol. 2774, 99-117
A Computational Modeling Approach for the Design of Genetic Control Systems that Respond to Transcriptional Activity
Recent progress in synthetic biology has enabled the design of complex genetic circuits that interface with innate cellular functions, such as gene transcription, and control user-defined outputs. Implementing these genetic networks in mammalian cells, however, is a cumbersome process that requires several steps of optimization and benefits from the use of predictive modeling. Combining deterministic mathematical models with software-based numerical computing platforms allows researchers to quickly design, evaluate, and optimize multiple circuit topologies to establish experimental constraints that generate the desired control systems. In this chapter, we present a systematic approach based on predictive mathematical modeling to guide the design and construction of gene activity-based sensors. This approach enables user-driven circuit optimization through iterations of sensitivity analyses and parameter scans, providing a universal method to engineer sense and respond cells for diverse applications. Key words Genetic control systems Sense-and-respond Genetic circuits Mammalian synthetic biology Cell therapies
- 15 August 2023
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 83, 102981
Editorial overview: Tissue, cell, and pathway engineering: Recent innovations in biomedical technologies
- 15 August 2023
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 83, 102981
Editorial overview: Tissue, cell, and pathway engineering: Recent innovations in biomedical technologies
- 21 April 2023
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 24 (5) , 2196-2202
Boronic Acid Resin for Selective Immobilization of Canonically Encoded Proteins
The use of transition-metal-mediated boronic acid chemistry presents a novel method of protein immobilization on a solid support. This is a one-step method that site-selectively immobilizes pyroglutamate-histidine (pGH)-tagged proteins. Herein, we describe the synthesis of alkenylboronic acid-functionalized poly(ethylene glycol) acrylamide (PEGA) resin and its subsequent reactions with pGH-tagged proteins to produce covalent linkages. The selectivity of immobilization is demonstrated within fluorescent studies, model mixtures, and lysates.
- 21 April 2023
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 24 (5) , 2196-2202
Boronic Acid Resin for Selective Immobilization of Canonically Encoded Proteins
The use of transition-metal-mediated boronic acid chemistry presents a novel method of protein immobilization on a solid support. This is a one-step method that site-selectively immobilizes pyroglutamate-histidine (pGH)-tagged proteins. Herein, we describe the synthesis of alkenylboronic acid-functionalized poly(ethylene glycol) acrylamide (PEGA) resin and its subsequent reactions with pGH-tagged proteins to produce covalent linkages. The selectivity of immobilization is demonstrated within fluorescent studies, model mixtures, and lysates.